title: Reply to J. Richter et al.
authors: Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles, France phrousselot@ch-versailles.fr.
authors: Philippe
authors: P
authors: Rousselot
authors: Institut Paoli Calmette, Marseille, France.
authors: Aude
authors: A
authors: Charbonnier
authors: Hôpital d'Annecy, Pringy, France.
authors: Pascale
authors: P
authors: Cony-Makhoul
authors: Hôpital Felix Guyon- Centre Hôpital Universitaire (CHU) de la Réunion, La Réunion, France.
authors: Philippe
authors: P
authors: Agape
authors: Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
authors: Franck E
authors: FE
authors: Nicolini
authors: Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes, Paris, France.
authors: Bruno
authors: B
authors: Varet
authors: CHU d'Angers, Angers, France.
authors: Martine
authors: M
authors: Gardembas
authors: Institut Bergonié, Bordeaux, France.
authors: Gabriel
authors: G
authors: Etienne
authors: Hôpital Saint-Louis, AP-HP, Paris, France.
authors: Delphine
authors: D
authors: Réa
authors: Institut National de la Sante' et de la Recherche Médicale (INSERM) Clinical Investigation Center (CIC) 802, CHU de Poitiers, Poitiers, France.
authors: Lydia
authors: L
authors: Roy
authors: Centre Hospitalier Pontchaillou, Rennes, France.
authors: Martine
authors: M
authors: Escoffre-Barbe
authors: CHU Brabois Vandoeuvre, Nancy, France.
authors: Agnès
authors: A
authors: Guerci-Bresler
authors: Hôpital Henri Mondor, AP-HP, Paris, France.
authors: Michel
authors: M
authors: Tulliez
authors: Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses, France.
authors: Stéphane
authors: S
authors: Prost
authors: Hôpital Mignot, Le Chesnay, France.
authors: Marc
authors: M
authors: Spentchian
authors: Hôpital Saint-Louis, AP-HP, Paris, France.
authors: Jean Michel
authors: JM
authors: Cayuela
authors: Institut Bergonié, Bordeaux, France.
authors: Josy
authors: J
authors: Reiffers
authors: INSERM U935, Université Poitiers et Paris Sud 11, Le Kremlin-Bicêtre, France.
authors: Jean Claude
authors: JC
authors: Chomel
authors: INSERM U935, Université Poitiers et Paris Sud 11, Le Kremlin-Bicêtre, France.
authors: Ali
authors: A
authors: Turhan
authors: INSERM CIC 802, CHU de Poitiers, Poitiers, France.
authors: Joëlle
authors: J
authors: Guilhot
authors: INSERM CIC 802, CHU de Poitiers, Poitiers, France.
authors: François
authors: F
authors: Guilhot
authors: INSERM U1035, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux, France.
authors: François-Xavier
authors: FX
authors: Mahon
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides / Q000008:administration & dosage*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D016044:Fusion Proteins, bcr-abl